Key Finding
A randomized controlled trial is underway to determine whether electroacupuncture administered three times weekly can significantly increase successful discontinuation rates of non-benzodiazepine sleep medications in adults with chronic insomnia disorder over a six-week structured tapering period.
If you've been relying on sleep medications for months and want to stop taking them, you know how difficult that process can be. A new clinical trial is exploring whether electroacupuncture — a form of acupuncture that uses gentle electrical stimulation through the needles — can make it easier to wean off a common class of sleep drugs called non-benzodiazepine hypnotics (sometimes known by brand names like Ambien or Lunesta).
Researchers are enrolling 78 adults who have been taking these medications for more than six months. Half will receive real electroacupuncture three times per week for six weeks, while the other half will receive a sham (fake) version that looks and feels similar but doesn't deliver true acupuncture stimulation. Everyone in the study will also follow a gradual medication tapering schedule and receive sleep hygiene education.
The acupuncture points being used include spots on the head, hands, feet, and wrists — many of which are traditionally associated with calming the mind and supporting restful sleep. These include well-known points like Baihui (top of the head), Yintang (between the eyebrows), and Sanyinjiao (lower leg).
The main goal is to see how many people successfully stop their sleep medication by the end of the six weeks. Researchers will also track sleep quality using questionnaires, wearable devices, and overnight sleep studies, along with measures of daytime functioning.
While this is a trial protocol — meaning the study is planned but results aren't yet available — it builds on earlier research suggesting acupuncture can meaningfully improve sleep. If the results are positive, electroacupuncture could become a valuable, low-risk tool to help people reduce their dependence on sleep medications.
If you're curious about acupuncture for sleep concerns, speak with a licensed acupuncturist or integrative medicine practitioner to discuss whether it may be right for you.
This registered RCT protocol (ITMCTR2025002446) investigates electroacupuncture (EA) as an adjunct to structured non-benzodiazepine hypnotic (NBZD) tapering in patients with chronic insomnia disorder (CID) per ICSD-3TR criteria. A total of 78 adults with NBZD use exceeding six months will be randomized 1:1 to verum EA or non-penetrative sham EA over six weeks (three sessions/week). Both arms follow an identical standardized tapering protocol and sleep hygiene education. Verum EA targets 12 predefined acupoints including Baihui (GV20), Sishencong (EX-HN1), Anmian, Shenting (GV24), Yintang (EX-HN3), Hegu (LI4), Taichong (LR3), Neiguan (PC6), Shenmen (HT7), Sanyinjiao (SP6), Shenmai (BL62), and Zhaohai (KI6). Primary outcome is NBZD discontinuation rate at week six. Secondary outcomes include PSG and actigraphy parameters, subjective sleep scales, and daytime functioning. Analysis follows intention-to-treat principles using mixed-effects models. This trial addresses a meaningful evidence gap in non-pharmacological tapering support strategies for CID.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Acupoint injection combined with manual acupuncture significantly improved sleep quality scores on the PSQI and ranked among the most effective and cost-efficient interventions for primary insomnia across 24 RCTs involving 1,851 participants.
📌 A combination of mindfulness-based stress reduction and acupressure produced the greatest improvement in sleep quality among breast cancer patients, achieving a mean difference of -5.04 points on the Pittsburgh Sleep Quality Index compared to control, and ranked highest for efficacy across all interventions assessed.
📌 Acupuncture improves subjective sleep quality and reduces hyperarousal in insomnia patients through multiple mechanisms, including autonomic nervous system modulation, HPA axis normalization, anti-inflammatory effects, and neuroimmune rebalancing.